New World Medical, Inc., often referred to simply as New World Medical, is a prominent player in the medical device industry, headquartered in the United States. Founded in 2004, the company has established itself as a leader in innovative surgical solutions, particularly in the field of glaucoma treatment. With a focus on developing advanced technologies, New World Medical is renowned for its flagship product, the Ahmed Glaucoma Valve, which offers unique benefits in managing intraocular pressure. The company operates primarily in North America and has expanded its reach to various international markets, solidifying its position as a trusted provider of ophthalmic devices. Recognised for its commitment to quality and innovation, New World Medical continues to achieve significant milestones, contributing to improved patient outcomes in eye care.
How does New World Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
New World Medical, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
New World Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that New World Medical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for New World Medical to consider developing and communicating its climate commitments to align with broader environmental goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
New World Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

